Blood

Vol. 147, Issue 13 Issue 13 2026
20
Articles

Articles in this Issue

It takes two to tango: <i>Enterococcus</i> boosts epithelial MHC-II

Dimitrios Mougiakakos Mar 26, 2026 pp. 1391-1393 10.1182/blood.2025032608

Ronceray L, Huibers MHW, Reutter K, et al. High-grade/large B-cell lymphoma-11q has a very good prognosis in children and young people without a predisposition. <i>Blood.</i> 2026;147(2):209-214.

Mar 26, 2026 pp. 1504-1504 10.1182/blood.2026033346

Beyond ATP: asciminib and the allosteric path in CML

Elisabetta Abruzzese Mar 26, 2026 pp. 1384-1386 10.1182/blood.2025032327

DNA methylation matters: methylation of the γ-globin ( <i>HBG</i> ) gene promoters is required for postnatal silencing of HbF

Gordon D. Ginder, Shengzhe Shang, David C. Williams Mar 26, 2026 pp. 1416-1422 10.1182/blood.2025031153

Abstract Sufficient levels of fetal hemoglobin (HbF) can ameliorate the pathophysiologic basis of sickle cell disease and β-thalassemia postnatally. DNA methylation has long been p...

Silencing of BCL11A by disrupting enhancer-dependent epigenetic insulation

Kaili Wang, Juan Wang, Ruopeng Feng et al. Mar 26, 2026 pp. 1470-1484 10.1182/blood.2025030211

Abstract The transcription factor BCL11A is a genetically and clinically validated regulator of the fetal-to-adult hemoglobin switch in human erythroid cells. CRISPR editing of an...

NLRP3 inflammasome blockade treats intestinal inflammation associated with chronic granulomatous disease

Emma Darbinian, Kodjovi D. Mlaga, Matheus Aranguren et al. Mar 26, 2026 pp. 1456-1469 10.1182/blood.2025029676

Abstract Chronic granulomatous disease (CGD) is an inborn error of immunity associated with a 50% prevalence of inflammatory bowel disease (IBD) for which current treatments are su...

Uncovering the genomic complexity of <i>PAX5</i> intragenic tandem multiplication via long-read and short-read sequencing

Yanling Liu, Bensheng Ju, Li Dong et al. Mar 26, 2026 pp. 1498-1502 10.1182/blood.2025031289

Abstract By integrating short-read whole-genome sequencing and RNA sequencing (RNA-seq) data with long-read RNA-seq, we dissect the complex genomic architecture of PAX5 intragenic...

Targeting enhancer RNAs to silence transcription

Andrew Charles Perkins Mar 26, 2026 pp. 1389-1391 10.1182/blood.2025032076

Comprehensive molecular and functional analysis of <i>NUTM1</i> -rearranged leukemia

Koutarou Nishimura, Tomoya Isobe, Tsukasa Shigehiro et al. Mar 26, 2026 pp. 1395-1411 10.1182/blood.2024026928

Abstract NUTM1 rearrangement defines a significant subset of B-cell acute lymphoblastic leukemia (B-ALL), particularly in infants lacking KMT2A rearrangements, yet its underlying m...

Time to revise myeloma diagnostic criteria? A decade of accumulated evidence on a serum free light chain ratio of ≥100

Rajshekhar Chakraborty, Ghulam Rehman Mohyuddin Mar 26, 2026 pp. 1412-1415 10.1182/blood.2025031907

Abstract In 2014, the International Myeloma Working Group (IMWG) expanded multiple myeloma diagnostic criteria to include a serum free light chain (sFLC) ratio of ≥100 as a standal...

Asciminib demonstrates superior efficacy and safety in newly diagnosed chronic myeloid leukemia in the ASC4FIRST trial

Jorge E. Cortes, Timothy P. Hughes, Jianxiang Wang et al. Mar 26, 2026 pp. 1433-1446 10.1182/blood.2025029210

Abstract Many patients receiving frontline tyrosine kinase inhibitors (TKIs) for chronic-phase chronic myeloid leukemia (CML-CP) experience inadequate disease control and/or advers...

Benchmarking clonal hematopoiesis in sickle cell disease

Ellen Nuttall Musson, Elspeth M. Payne Mar 26, 2026 pp. 1386-1387 10.1182/blood.2025032118

Ketones and the NLRP3 inflammasome: you are what you eat

Andrew R. Gennery Mar 26, 2026 pp. 1387-1389 10.1182/blood.2025032445

Increased prevalence of clonal hematopoiesis in children with sickle cell disease

Jessica Ulloa, Kristin Wuichet, Sara R. Rashkin et al. Mar 26, 2026 pp. 1447-1455 10.1182/blood.2025030898

Abstract Recent studies have reached opposing conclusions about whether clonal hematopoiesis (CH) is increased or decreased in patients with sickle cell disease (SCD). Given that C...

Jaye DL, Feldman AL. ALK-negative anaplastic large cell lymphoma with <i>JAK2</i> rearrangement mimicking classic Hodgkin lymphoma. <i>Blood</i> . 2023;141(17):2160.

Mar 26, 2026 pp. 1504-1504 10.1182/blood.2026033656

Cracking the nut of <i>NUTM1</i> rearrangements in infant leukemia

Ruth Shiloh, Shai Izraeli Mar 26, 2026 pp. 1383-1384 10.1182/blood.2025032530

Myelodysplastic CMML-1 mimicking ITP, unmasked by corticosteroids: evolution from clonal monocytosis

Zhaodong XU, Monika Hudoba Mar 26, 2026 pp. 1503-1503 10.1182/blood.2025032170

Evolution of multiple myeloma from a genomic perspective

Francesco Maura, Mehmet Samur, Nikhil Munshi Mar 26, 2026 pp. 1423-1432 10.1182/blood.2024026313

Abstract In this review, we explore the role of complex interactions between genomic evolution, environmental and genetic predispositions, and immune surveillance in disease progre...

<i>Enterococcus faecalis</i> induces MHC-II expression by the intestinal epithelium during murine graft-versus-host disease

Chi L. Nguyen, Jennifer Funes, Romina Ghale et al. Mar 26, 2026 pp. 1485-1497 10.1182/blood.2024028248

Abstract Intestinal Enterococcus domination has been associated with an increased risk of mortality from acute graft-versus-host disease (GVHD) after allogeneic hematopoietic cell...

Mandato E, Yan Q, Ouyang J, et al. MYD88L265P augments proximal B-cell receptor signaling in large B-cell lymphomas via an Interaction with DOCK8. <i>Blood</i> . 2023;142(14):1219-1232.

Mar 26, 2026 pp. 1505-1507 10.1182/blood.2026033438

All Issues

Journal Info

Publisher Elsevier BV
ISSN 0006-4971
E-ISSN 1528-0020
Subject Health Sciences
Language English
View Full Journal Page